AbstractThe seven-valent pneumococcal conjugate vaccine (PCV7) was added to the UK national immunisation programme in September 2006. PCV13 replaced PCV7 in April 2010. As carriage precedes disease cases this study collected carried pneumococci from children each winter from 2006/7 to 2010/11 over PCV introduction. Conventional microbiology and whole genome sequencing were utilised to characterise pneumococcal strains.Overall prevalence of pneumococcal carriage remained stable. Vaccine serotypes (VT) decreased (p<0.0001) with concomitant increases in non-vaccine serotypes (NVT). In winter 2010/11 only one isolate of PCV7 VT was observed (6B). PCV13 unique VTs decreased between winters immediately preceding and following PCV13 introduction (...
BACKGROUND: We investigated the effect of the 7-valent pneumococcal conjugate vaccine (PCV7) program...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...
After heptavalent pneumococcal conjugate vaccine (PCV7) was marketed in France, Spain, Belgium, and ...
The seven-valent pneumococcal conjugate vaccine (PCV7) was added to the UK national immunisation pro...
BACKGROUND: In April 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced PCV7 in the inf...
BACKGROUND: Monitoring changes in pharyngeal carriage of pneumococcus in children following 13-valen...
Streptococcus pneumoniae, also known as the pneumococcus, is an important cause of morbidity and mor...
In April 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced PCV7 in the infant immunisa...
Streptococcus pneumoniae is a major cause of meningitis, sepsis and pneumonia worldwide. Vaccination...
We investigated the effect of the 7-valent pneumococcal conjugate vaccine (PCV7) programme in Englan...
<div><p>Background</p><p>In April 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced PC...
AbstractIntroductionThe 7-valent pneumococcal conjugate vaccine (Prevenar®, Wyeth; PCV7) was introdu...
Serotype replacement has been reported in carriage and disease after pneumococcal conjugate vaccine ...
BACKGROUND: The UK introduced the 7-valent pneumococcal conjugate vaccine (PCV7) into the national v...
After heptavalent pneumococcal conjugate vaccine (PCV7) was marketed in France, Spain, Belgium, and ...
BACKGROUND: We investigated the effect of the 7-valent pneumococcal conjugate vaccine (PCV7) program...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...
After heptavalent pneumococcal conjugate vaccine (PCV7) was marketed in France, Spain, Belgium, and ...
The seven-valent pneumococcal conjugate vaccine (PCV7) was added to the UK national immunisation pro...
BACKGROUND: In April 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced PCV7 in the inf...
BACKGROUND: Monitoring changes in pharyngeal carriage of pneumococcus in children following 13-valen...
Streptococcus pneumoniae, also known as the pneumococcus, is an important cause of morbidity and mor...
In April 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced PCV7 in the infant immunisa...
Streptococcus pneumoniae is a major cause of meningitis, sepsis and pneumonia worldwide. Vaccination...
We investigated the effect of the 7-valent pneumococcal conjugate vaccine (PCV7) programme in Englan...
<div><p>Background</p><p>In April 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced PC...
AbstractIntroductionThe 7-valent pneumococcal conjugate vaccine (Prevenar®, Wyeth; PCV7) was introdu...
Serotype replacement has been reported in carriage and disease after pneumococcal conjugate vaccine ...
BACKGROUND: The UK introduced the 7-valent pneumococcal conjugate vaccine (PCV7) into the national v...
After heptavalent pneumococcal conjugate vaccine (PCV7) was marketed in France, Spain, Belgium, and ...
BACKGROUND: We investigated the effect of the 7-valent pneumococcal conjugate vaccine (PCV7) program...
AbstractThe implementation of the seven-valent pneumococcal conjugate vaccine, PCV7, has resulted in...
After heptavalent pneumococcal conjugate vaccine (PCV7) was marketed in France, Spain, Belgium, and ...